Navigation Links
Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions
Date:7/25/2014

Washington, DC (PRWEB) July 25, 2014

CMS recently has imposed a series of stiff sanctions against some health plans for providing inadequate access to prescription drugs. Agency audits are uncovering violations that pose serious threats to the health and safety of beneficiaries in areas such as rejected pharmacy claims and misclassifications of drug coverage determinations, and CMS is taking quick and firm actions to halt them. On Aug. 5, the Atlantic Information Services webinar, “Avoiding Costly Part D Sanctions: Rx Access Strategies for Plans and PBMs,” will provide the details of what CMS is looking for and steps can be taken to make sure plans and PBMs don’t wind up in the crosshairs of government regulators.

Steve Arbaugh, managing principal and CEO of ATTAC Consulting Group, LLC, Jane Galvin, managing director of regulatory affairs for the BlueCross and BlueShield Association, and Anne Hance, partner in the McDermott Will & Emery law firm, will analyze the CMS requirements that are causing plans so much trouble and offer strategies plans and their partners can institute to prevent pharmaceutical-access problems. In a lively 60-minute presentation, followed by 30 minutes of responses to individual questions, they will provide answers to these and other questions:

  • What are the statutory and regulatory requirements regarding access to pharmaceuticals in Part D? How are they likely to change in the near future?
  • What is CMS finding in terms of violations of drug-access standards in its audits and via member complaints? What actions is the agency taking in response, including civil monetary penalties and intermediate sanctions?
  • What steps does CMS expect Part D plans to take to monitor and oversee their PBMs?
  • What specifically are regulators looking for in plans’ policies on the use of prior authorization, step therapy and transition supplies of medications?
  • How do CMS’s recent revisions to the Notice of Denial of Medicare Prescription Drug Coverage change the requirements that plans and their partners must comply with?
  • What do regulators expect from plans in their handling of protests and appeals of coverage determinations on pharmaceuticals?
  • How should plans and PBMs administer formularies to avoid access problems despite the necessity for frequent changes?
  • What does CMS expect in terms of outreach to prescribers and beneficiaries on pharmaceutical-access issues? What operational and other strategies should plans employ to accomplish this?

Visit http://aishealth.com/marketplace/c4a33_080514 for more details and registration information.

About AIS
Atlantic Information Services, Inc. (AIS) is a publishing and information company that has been serving the health care industry for more than 25 years. It develops highly targeted news, data and strategic information for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. AIS products include print and electronic newsletters, websites, looseleafs, books, strategic reports, databases, webinars and conferences. Learn more at http://www.AISHealth.com.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12040970.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st
2. Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow
3. Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness
4. Scottsdale Senior Care Company Partners with Licensed Clinical Social Worker and Award-Winning Author to Host Webinar on Caregiver Mindfulness
5. Mahendra Trivedi and Trivedi Master™ Alice Branton to host a Live Webinar
6. FDAnews Announces — Choosing the Right Drug Name: How to Increase Your Chances for Approval Webinar, July 22, 2014
7. FDAnews Announces — Improving Your FDA Import Success Rate: Tips for Thinking Ahead of the FDAWebinar, Aug. 7, 2014
8. Home Care Assistance South Fairfield County to Host Public Webinar on the Topic of Caregiver Mindfulness
9. Pioneering Webinars on the Business of Cannabis Start August 7 with Mike “Zappy” Zapolin & Leading Entrepreneurs; Produced by Evolver Learning Lab
10. DIA Webinar With Veeva to Provide Insight on Improving Transparency
11. FDAnews Announces Device Software Verification and Validation: Get Ready for a New Breed of Investigators, On-Demand Webinar, Aug. 12, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... Eating disorders ... that every 62 minutes, at least one person dies as a direct result from ... greater need exists for qualified treatment providers. The iaedp Foundation meets this challenge by ...
(Date:6/28/2017)... ... 28, 2017 , ... American Farmer proudly announces the participation of Pure Line ... series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on ... garden pea seed. As demand grew, the small company located in Moscow, Idaho extended ...
(Date:6/28/2017)... MT (PRWEB) , ... June 28, 2017 , ... ... provides insurance management and financial planning assistance to clients in southern Montana, is ... programs offered by Zoo Montana. , The outreach programs offered by Zoo Montana ...
(Date:6/28/2017)... Cincinnati, OH (PRWEB) , ... June 28, 2017 ... ... and financial consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is ... help provide temporary lodgings for families with children receiving treatment in nearby hospitals. ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
(Date:6/9/2017)... and INDIANAPOLIS , June 9, 2017 ... with diabetes. In a further effort to help spread ... by this condition, the International Diabetes Federation (IDF) and ... have come together for the second phase of the ... programme (BRIDGES 2), reaffirming their commitment to helping people ...
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
Breaking Medicine Technology: